Healthcare
Wednesday, September 21, 2016
BRIEF-BiondVax Phase 2b European Trial: Last Patient Out
* Last participant in a European phase 2b clinical trial of
M-001, its universal flu vaccine candidate, has completed final
visit
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment